Evaluation of topotecan and etoposide for non-Hodgkin lymphoma - Correlation of topoisomerase-DNA complex formation with clinical response Article

Kancherla, RR, Nair, JS, Ahmed, T et al. (2001). Evaluation of topotecan and etoposide for non-Hodgkin lymphoma - Correlation of topoisomerase-DNA complex formation with clinical response . CANCER, 91(3), 463-471. 10.1002/1097-0142(20010201)91:3<463::AID-CNCR1023>3.0.CO;2-R

Open Access

cited authors

  • Kancherla, RR; Nair, JS; Ahmed, T; Durrani, H; Seiter, K; Mannancheril, A; Tse-Dinh, YC

sustainable development goals

authors

publication date

  • February 1, 2001

webpage

published in

keywords

  • ACUTE-LEUKEMIA
  • CAMPTOTHECIN
  • CANCER
  • CELLS
  • I-INHIBITOR TOPOTECAN
  • Life Sciences & Biomedicine
  • MECHANISM
  • Oncology
  • PHASE-I
  • PROLIFERATION
  • REPLICATION
  • SENSITIVITY
  • Science & Technology
  • etoposide
  • non-Hodgkin lymphoma
  • salvage chemotherapy
  • topoisomerase-DNA complexes
  • topotecan

Location

  • NEW ORLEANS, LOUISIANA

publisher

  • WILEY-LISS

start page

  • 463

end page

  • 471

volume

  • 91

issue

  • 3